Trials / Completed
CompletedNCT05721066
Hemostatic Profile of Post COVID-19/Long COVID-19 Patients
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 102 (actual)
- Sponsor
- IRCCS Policlinico S. Donato · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The present study aims at assessing long-term hemostatic profile of patients recovered from COVID-19 acute infection that remain asymptomatic (POST-COVID) versus patients with residual symptoms (LONG-COVID) through the employment of a commercially available new generation point-of-care viscoelastic device. The primary endpoint is based upon the hypothesis that patients with residual symptoms maintain an abnormal coagulation profile even after recovery from COVID-19.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | ClotPro assessment | Point-of-care viscoelastic assessment of the coagulation profile (extrinsic pathway, intrinsic pathway, fibrinogen contribution, tPA stimulated fibrinolysis) |
| DIAGNOSTIC_TEST | Laboratory analysis | Blood count and standard coagulation tests (INR, aPTT, fibrinogen, D-dimers, antithrombin) |
| OTHER | Interview | Questionnaire from ISS (Istituto Superiore Sanità, the National Health Institute) about the health conditions before the acute COVID-19 infection, the disease (and the hospitalization) details and the eventual health disturbances experienced after the recovery from COVID-19 infection. |
Timeline
- Start date
- 2022-04-12
- Primary completion
- 2022-11-15
- Completion
- 2022-11-15
- First posted
- 2023-02-09
- Last updated
- 2023-02-16
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT05721066. Inclusion in this directory is not an endorsement.